Skip to content

Community Participation Transition After Stroke

Feasibility of a Novel Intervention to Improve Participation After Stroke

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02396589
Acronym
COMPASS
Enrollment
15
Registered
2015-03-24
Start date
2015-01-19
Completion date
2016-12-13
Last updated
2025-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

stroke rehabilitation, barriers to independence, environmental support

Brief summary

Stroke is one of the most serious, disabling health conditions in the United States. Patients who undergo rehabilitation treatment for stroke have a high rate of disability. Poor outcomes for many persons with stroke may be low because of incomplete treatment. The investigators will conduct a randomized controlled trial and a process evaluation to examine the feasibility, safety, and preliminary efficacy of an enhanced rehabilitation transition program, Community Participation Transition after Stroke (COMPASS), designed to bridge inpatient rehabilitation and the home to support the performance of everyday activities.

Detailed description

We propose an enhanced rehabilitation transition program: Community Participation Transition after Stroke (COMPASS) is a compensatory intervention consisting of one pre-discharge and five post-discharge home visits by an occupational therapist to supplement usual care. This intervention is focused on resolving barriers to independence in daily activities and participation using environmental support and active practice of daily activities in an individual's real home (versus an idealized clinical setting). This is a new combination of evidence-based compensatory treatments delivered in a novel treatment setting (transition to home). Our long-term goal is the development of an effective intervention for a transition home designed to prevent excess disability for people living with stroke that could have an immediate effect and high public health significance.16 We will recruit 40 patients currently undergoing inpatient rehabilitation (IR) for ischemic stroke from longitudinal studies of stroke at Washington University School of Medicine (WUSM) and randomize them to receive six additional sessions of the enhanced rehabilitation transition program or attention control. Exploratory participation outcomes will be assessed by blinded evaluators at baseline, 6 months, 9 months, and 12 months after stroke. We will test the central hypothesis that COMPASS will be acceptable, feasible, and superior to attention control on measures of participation and daily activity performance at 6 months after stroke.

Interventions

BEHAVIORALEducation Group

Attention will be provided to the control group to ensure they experience the same effects of time and attention but no effect on the outcome of interest.

BEHAVIORALHome Modifications Group

The standardized components include assessment, identification of five problematic activities (and environmental barriers), identification of three solutions (for each problem), implementation of a solution set selected by the participant, training, and active practice of daily activities in one's own home and community.

Sponsors

Washington University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. ≥45 years old 2. acute ischemic stroke, verified by a neurologist 3. baseline National Institutes of Health Stroke Scale (NIHSS) ≥8 4. independent in activities of daily living prior to stroke (premorbid Rankin score of ≤2) 5. plan to discharge to home

Exclusion criteria

1. severe terminal systemic disease that limits life expectancy to \<6 months 2. previous disorder (e.g., dementia) that makes interpretation of the self-rated scales difficult or a Short Blessed Test (SBT) score of ≥9 (indicating significant cognitive impairment) 3. moderate to severe aphasia, as determined by the NIHSS Best Language rating of ≥2 4. residence in a congregate living facility 5. not eligible for a therapeutic pass

Design outcomes

Primary

MeasureTime frameDescription
Rate and Severity of Falls (Calculated With an Algorithm)12 monthsWe will explore the safety of the intervention by determining the rate and severity of falls (calculated with an algorithm). Scores are as follows: 0, those with no falls, 1, those with one fall without serious injury, 2, those with at least two falls without serious injury, and 3, those with one or more falls causing serious injury. Maximum score of three indicates an increased severity of fall. We will compare the difference in scores between groups using t-tests.

Secondary

MeasureTime frameDescription
Intervention Dose (Minutes)2 monthsThe does of the intervention as measured in minutes received by both groups. The number of minutes reported is the average of the total for each participant in each group.
Health Care Utilization, Number of Emergency Department Visits12 monthsWe analyzed health care utilization by examining the number of emergency department visits, outpatient physical and occupational therapy visits, and doctor visits. The total number of each was calculated for each participant and the average is reported here.
Intervention Dose, Number of Treatment Sessions2 monthsThe does of the intervention as measured by amount of treatment minutes received by both groups. The total number of treatment sessions was calculated for each participant and the average is reported here.
Health Care Utilization, Days of Hospitalization12 monthsWe analyzed health care utilization by examining the number of days participants in each group spent in the hospital. The total number of days was calculated for participants in each group and the average is reported here.

Other

MeasureTime frameDescription
Intervention Adherence9 monthsAdherence to the intervention will be measured by examine the number of recommendations implemented per recommendations suggested. Long-term adherence will be calculated as the number of recommendations used at 9 months per recommendations suggested.

Countries

United States

Participant flow

Participants by arm

ArmCount
Education Group
Participants in the Education group receive five 90 minute tailored stroke education sessions in the home. Education Group: Attention will be provided to the control group to ensure they experience the same effects of time and attention but no effect on the outcome of interest.
6
Home Modifications Group
Participants in the treatment group receive a home assessment and home modifications tailored to functional abilities (pre discharge) and then five 90 minute occupational therapy treatment sessions at home (post discharge) to improve functional abilities and community participation. Home Modifications Group: The standardized components include assessment, identification of five problematic activities (and environmental barriers), identification of three solutions (for each problem), implementation of a solution set selected by the participant, training, and active practice of daily activities in one's own home and community.
9
Total15

Withdrawals & dropouts

PeriodReasonFG000FG001
12 Month Follow upLost to Follow-up02
6 Month Follow-upchange in health status01
9 Month Follow-upDeath01
InterventionLost to Follow-up10

Baseline characteristics

CharacteristicEducation GroupHome Modifications GroupTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
3 Participants5 Participants8 Participants
Age, Categorical
Between 18 and 65 years
3 Participants4 Participants7 Participants
Age, Continuous64.7 years
STANDARD_DEVIATION 8.21
66.9 years
STANDARD_DEVIATION 7.96
66.0 years
STANDARD_DEVIATION 7.85
I-HOPE Environmental Barriers58.67 barrier score
STANDARD_DEVIATION 35.01
85.44 barrier score
STANDARD_DEVIATION 22.47
74.73 barrier score
STANDARD_DEVIATION 30.18
I-HOPE Satisfaction16.67 units on a scale
STANDARD_DEVIATION 9.4
19.33 units on a scale
STANDARD_DEVIATION 5.94
18.27 units on a scale
STANDARD_DEVIATION 7.31
In-Home Occupational Performance Measure (I-HOPE) Performance16.00 units on a scale
STANDARD_DEVIATION 7.72
21.22 units on a scale
STANDARD_DEVIATION 5.76
19.13 units on a scale
STANDARD_DEVIATION 6.88
Length of Stay in Inpatient Rehabilitation16.7 days
STANDARD_DEVIATION 53.5
24.1 days
STANDARD_DEVIATION 7.9
21.1 days
STANDARD_DEVIATION 7.8
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
5 Participants4 Participants9 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
1 Participants5 Participants6 Participants
Region of Enrollment
United States
6 participants9 participants15 participants
Reintegration to Normal Living Index (RNLI)62.88 units on a scale
STANDARD_DEVIATION 22.24
52.73 units on a scale
STANDARD_DEVIATION 18.87
56.79 units on a scale
STANDARD_DEVIATION 20.12
Sex: Female, Male
Female
1 Participants3 Participants4 Participants
Sex: Female, Male
Male
5 Participants6 Participants11 Participants
SIS Activity of Daily Living (ADL) Subscale52.83 units on a scale
STANDARD_DEVIATION 15.03
37.11 units on a scale
STANDARD_DEVIATION 17.09
43.4 units on a scale
STANDARD_DEVIATION 17.64
Stroke Impact Scale (SIS) Total40.83 units on a scale
STANDARD_DEVIATION 22
38.33 units on a scale
STANDARD_DEVIATION 21.79
39.33 units on a scale
STANDARD_DEVIATION 21.12

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 61 / 9
other
Total, other adverse events
0 / 60 / 9
serious
Total, serious adverse events
0 / 60 / 9

Outcome results

Primary

Rate and Severity of Falls (Calculated With an Algorithm)

We will explore the safety of the intervention by determining the rate and severity of falls (calculated with an algorithm). Scores are as follows: 0, those with no falls, 1, those with one fall without serious injury, 2, those with at least two falls without serious injury, and 3, those with one or more falls causing serious injury. Maximum score of three indicates an increased severity of fall. We will compare the difference in scores between groups using t-tests.

Time frame: 12 months

Population: 15 participants were randomized (treatment group n=9 and education group n=6). 12 participants were included in this analysis. One participant in the education group was not able to finish education visits and was excluded from the analysis. Two participants in the treatment group were lost to follow up (drop out due to change in health n=1, drop out due to death n=1), and were excluded from analysis.

ArmMeasureValue (MEAN)Dispersion
Education GroupRate and Severity of Falls (Calculated With an Algorithm)2 score on a scaleStandard Deviation 0.316
Home Modifications GroupRate and Severity of Falls (Calculated With an Algorithm)2 score on a scaleStandard Deviation 0
Secondary

Health Care Utilization, Days of Hospitalization

We analyzed health care utilization by examining the number of days participants in each group spent in the hospital. The total number of days was calculated for participants in each group and the average is reported here.

Time frame: 12 months

Population: 15 participants were randomized (treatment group n=9 and education group n=6). 12 participants were included in this analysis. One participant in the education group was not able to finish education visits and was excluded from the analysis. Two participants in the treatment group were lost to follow up (drop out due to change in health n=1, drop out due to death n=1), and were excluded from analysis.

ArmMeasureValue (MEAN)Dispersion
Education GroupHealth Care Utilization, Days of Hospitalization0 daysStandard Deviation 0
Home Modifications GroupHealth Care Utilization, Days of Hospitalization.67 daysStandard Deviation 1.12
Secondary

Health Care Utilization, Number of Emergency Department Visits

We analyzed health care utilization by examining the number of emergency department visits, outpatient physical and occupational therapy visits, and doctor visits. The total number of each was calculated for each participant and the average is reported here.

Time frame: 12 months

Population: 15 participants were randomized (treatment group n=9 and education group n=6). 12 participants were included in this analysis. One participant in the education group was not able to finish education visits and was excluded from the analysis. Two participants in the treatment group were lost to follow up (drop out due to change in health n=1, drop out due to death n=1), and were excluded from analysis.

ArmMeasureGroupValue (MEAN)Dispersion
Education GroupHealth Care Utilization, Number of Emergency Department VisitsEmergency Room Visits.50 Number of visitsStandard Deviation 0.55
Education GroupHealth Care Utilization, Number of Emergency Department VisitsOutpatient physical therapy visits28.67 Number of visitsStandard Deviation 34.72
Education GroupHealth Care Utilization, Number of Emergency Department VisitsOutpatient occupational therapy visits36.00 Number of visitsStandard Deviation 36.3
Education GroupHealth Care Utilization, Number of Emergency Department VisitsOutpatient doctor visits10.33 Number of visitsStandard Deviation 10.86
Home Modifications GroupHealth Care Utilization, Number of Emergency Department VisitsOutpatient doctor visits26.11 Number of visitsStandard Deviation 30.1
Home Modifications GroupHealth Care Utilization, Number of Emergency Department VisitsEmergency Room Visits.56 Number of visitsStandard Deviation 0.88
Home Modifications GroupHealth Care Utilization, Number of Emergency Department VisitsOutpatient occupational therapy visits19.44 Number of visitsStandard Deviation 24.14
Home Modifications GroupHealth Care Utilization, Number of Emergency Department VisitsOutpatient physical therapy visits26.11 Number of visitsStandard Deviation 30.1
Secondary

Intervention Dose (Minutes)

The does of the intervention as measured in minutes received by both groups. The number of minutes reported is the average of the total for each participant in each group.

Time frame: 2 months

Population: A total of 14 participants were analyzed. One participant in the education group was not able to finish the education visits and was excluded from this analysis.

ArmMeasureValue (MEAN)Dispersion
Education GroupIntervention Dose (Minutes)354.8 number of treatment minutesStandard Deviation 120.1
Home Modifications GroupIntervention Dose (Minutes)365 number of treatment minutesStandard Deviation 108.3
Secondary

Intervention Dose, Number of Treatment Sessions

The does of the intervention as measured by amount of treatment minutes received by both groups. The total number of treatment sessions was calculated for each participant and the average is reported here.

Time frame: 2 months

Population: A total of 14 participants were analyzed. One participant in the education group was not able to finish the education visits and was excluded from this analysis.

ArmMeasureValue (MEAN)Dispersion
Education GroupIntervention Dose, Number of Treatment Sessions4.4 number of treatment sessionsStandard Deviation 1.3
Home Modifications GroupIntervention Dose, Number of Treatment Sessions5 number of treatment sessionsStandard Deviation 1
Other Pre-specified

Intervention Adherence

Adherence to the intervention will be measured by examine the number of recommendations implemented per recommendations suggested. Long-term adherence will be calculated as the number of recommendations used at 9 months per recommendations suggested.

Time frame: 9 months

Population: 9 participants were randomized to the treatment group. 7 participants were included in this analysis. Two participants in the treatment group were lost to follow up (drop out due to change in health n=1, drop out due to death n=1), and were excluded from analysis.

ArmMeasureValue (MEAN)Dispersion
Education GroupIntervention Adherence71.25 percentage of recommendations usedStandard Deviation 31

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026